Calcipotriol: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
In mouse studies, topical calcipotriol administration to the ear and dorsal skin led to a dose-dependent increase in the production of the epithelial cell-derived cytokine TSLP by keratinocytes, and triggered atopic dermatitis at high concentrations.<ref name="a10">PMID:16880407</ref> This upregulation of TSLP production due to calcipotriol application is thought to be mediated through the coactivation of [[vitamin D receptor]]/[[Retinoid X receptor]] α and [[vitamin D receptor]]/[[Retinoid X receptor]] β heterodimers. | In mouse studies, topical calcipotriol administration to the ear and dorsal skin led to a dose-dependent increase in the production of the epithelial cell-derived cytokine TSLP by keratinocytes, and triggered atopic dermatitis at high concentrations.<ref name="a10">PMID:16880407</ref> This upregulation of TSLP production due to calcipotriol application is thought to be mediated through the coactivation of [[vitamin D receptor]]/[[Retinoid X receptor]] α and [[vitamin D receptor]]/[[Retinoid X receptor]] β heterodimers. | ||
[[1s19]]. | <scene name='10/1023614/Cv/2'>VDR ligand binding domain complexed to calcipotriol</scene> ([[1s19]]). | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 13:21, 22 January 2024
| ||||||||||||